Anavex Alzheimer's And Parkinson's Drug Underappreciated By Investors
Seeking Alpha,
Summary Anavex's Alzheimer's drug Blarcamesine demonstrates strong statistical significance in improving cognition among…
Summary Anavex's Alzheimer's drug Blarcamesine demonstrates strong statistical significance in improving cognition among…
Alzheimer disease (AD) is a disorder that causes progressive cognitive deterioration and affects behavior and functional status.
Summary Recently, IPO’d Coya has just reported cognition-improving and cognition-stabilizing results in an open label study in…
Follow Summary In the now-published results for lecanemab, the latest attempt at anti-amyloid antibody therapy for Alzheimer’s…